Pharmacokinetics in Critically Ill Children with Acute Kidney Injury

Paediatr Drugs. 2023 Jun 2. doi: 10.1007/s40272-023-00572-z. Online ahead of print.ABSTRACTAcute kidney injury (AKI) is a commonly encountered comorbidity in critically ill children. The coexistence of AKI disturbs drug pharmacokinetics and pharmacodynamics, leading to clinically significant consequences. This can complicate an already critical clinical scenario by causing potential underdosing or overdosing giving way to possible therapeutic failures and adverse reactions. Current available studies offer little guidance to help maneuver such complex dosing regimens and decision-making in pediatric patients as most of them are done on heterogeneous groups of adult populations. Though there are some studies on drug dosing during continuous renal replacement therapy (CRRT), their utility is in question because of the recent advances in CRRT technology. Our review aims to discuss the principles of pharmacokinetics pertinent for honing the existing practices of drug dosing in critically ill children with AKI, and the various complexities and intricate challenges involved. This in turn will provide a framework to help enable caretakers to tailor dosing regimens in complex clinical setups with further ease and precision.PMID:37266815 | DOI:10.1007/s40272-023-00572-z
Source: Paediatric Drugs - Category: Pediatrics Authors: Source Type: research